Nu-Life Solutions is the developer of Nu-V3, the miniaturized, wearable, non-invasive, non-pharmaceutical device and treatment program for those suffering from acute and chronic pain, anxiety, depression and sleeplessness and delivers Nu-V3 through exclusive providers such as Nu-Life USA, Nu-Life Europe, Nu-Life Japan, Nu-Life Latin America and Nu-Life Canada. Each Nu-V3 provider holds exclusive distribution and patent rights and adheres to all quality standards set by Nu-Life Solutions.
Opportunity and Responsibility
Pain, anxiety, depression and sleeplessness know no boundaries. The empowered or the underserved. The wealthy or the needy. The young and the aged. Nu-Life is committed to treating people in need from all walks of life.
Three Distinct Treatment Program Models
The Nu-Life team has developed three treatment program models and a comprehensive telemedicine and tele-health platform to help ensure any patient who needs Nu-V3 will have access.
From Pre-Market to Full Market Entry
As the Nu-Life team prepares for market entry and operations upon regulatory clearance, they are fine tuning these treatment program models to ensure a smooth transition from our pre-market programs to full market entry.
The H.O.P.E. Initiative - Helping Our Protectors Endure
Nu-Life is preparing for market entry by launching The H.O.P.E. Initiative, treating healthcare workers, first responders and veterans under our IRB approved clinical programs.
